Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells

European Journal of Immunology

Volumn 42, Issue 7, 2012, Pages 1815-1821

  Otten, Marielle A ^a,b   Bakema, Jantine E ^b   Tuk, Cornelis W ^b   Glennie, Martin J ^c   Tutt, Alison L ^c   Beelen, Robert H J ^b   van de Winkel, Jan G J ^a,d   van Egmond, Marjolein ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d GENMAB   (Netherlands)

Author keywords

Bispecific antibody; Chemotaxis immunotherapy; HUVEC; IgA

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CARCINOMA CELL; CONTROLLED STUDY; DEGRANULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR CELL DESTRUCTION;

ANTIGENS, CD; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; CHEMOTAXIS, LEUKOCYTE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; NEUTROPHILS; RECEPTORS, FC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864007800     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141982     Document Type: Article

References (34)

1. Lieschke, G. J. and Burgess, A. W., Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N. Engl. J. Med. 1992. 327: 99-106.
2. Lichtenstein, A. and Kahle, J., Anti-tumor effect of inflammatory neutrophils: characteristics of in vivo generation and in vitro tumor cell lysis. Int. J. Cancer 1985. 35: 121-127.
3. Midorikawa, Y., Yamashita, T. and Sendo, F., Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selective depletion of neutrophils in vivo. Cancer Res. 1990. 50: 6243-6247.
4. Seino, K., Kayagaki, N., Okumura, K. and Yagita, H., Antitumor effect of locally produced CD95 ligand. Nat. Med. 1997. 3: 165-170.
5. Mantovani, A., Cassatella, M. A., Costantini, C. and Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011. 11: 519-531.
6. Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L. et al., Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010. 115: 335-343.
7. Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P. et al., T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009. 31: 787-798.
8. Valerius, T., Wurflein, D., Stockmeyer, B., Repp, R., Kalden, J. R. and Gramatzki, M., Activated neutrophils as effector cells for bispecific antibodies. Cancer Immunol. Immunother 1997. 45: 142-145.
9. Otten, M. A., Rudolph, E., Dechant, M., Tuk, C. W., Reijmers, R. M., Beelen, R. H., van de Winkel, J. G. et al., Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J. Immunol. 2005. 174: 5472-5480.
10. Stockmeyer, B., Valerius, T., Repp, R., Heijnen, I. A., Buhring, H. J., Deo, Y. M., Kalden, J. R. et al., Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res. 1997. 57: 696-701.
11. Valerius, T., Stockmeyer, B., van Spriel, A. B., Graziano, R. F., van den Herik-Oudijk, I. E., Repp, R., Deo, Y. M. et al., FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy. Blood 1997. 90: 4485-4492.
12. Deo, Y. M., Sundarapandiyan, K., Keler, T., Wallace, P. K. and Graziano, R. F., Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. J. Immunol. 1998. 160: 1677-1686.
13. Stockmeyer, B., Dechant, M., van Egmond, M., Tutt, A. L., Sundarapandiyan, K., Graziano, R. F., Repp, R. et al., Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 2000. 165: 5954-5961.
14. Keler, T., Wallace, P. K., Vitale, L. A., Russoniello, C., Sundarapandiyan, K., Graziano, R. F. and Deo, Y. M., Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages. J. Immunol. 2000. 164: 5746-5752.
15. Dechant, M. and Valerius, T., IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 2001. 39: 69-77.
16. Dechant, M., Vidarsson, G., Stockmeyer, B., Repp, R., Glennie, M. J., Gramatzki, M., van De Winkel, J. G. et al., Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood 2002. 100: 4574-4580.
17. Dechant, M., Beyer, T., Schneider-Merck, T., Weisner, W., Peipp, M., van de Winkel, J. G. and Valerius, T., Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor. J. Immunol. 2007. 179: 2936-2943.
18. Zhao, J., Kuroki, M., Shibaguchi, H., Wang, L., Huo, Q., Takami, N., Tanaka, T. and Kinugasa, T., Recombinant human monoclonal IgA antibody against CEA to recruit neutrophils to CEA-expressing cells. Oncol. Res. 2008. 17: 217-222.
19. Lohse, S., Derer, S., Beyer, T., Klausz, K., Peipp, M., Leusen, J. H., van de Winkel, J. G. et al., Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing. J. Immunol. 2011. 186: 3770-3778.
20. Bakema, J. E., Ganzevles, S. H., Fluitsma, D. M., Schilham, M. W., Beelen, R. H., Valerius, T., Lohse, S. et al., Targeting Fc{alpha}RI on polymorphonuclear cells induces tumor cell killing through autophagy. J. Immunol. 2011.
21. van der Steen, L., Tuk, C. W., Bakema, J. E., Kooij, G., Reijerkerk, A., Vidarsson, G., Bouma, G. et al., Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology 2009. 137: 2018-2029, e2011-e2013.
22. van Egmond, M., van Vuuren, A. J., Morton, H. C., van Spriel, A. B., Shen, L., Hofhuis, F. M., Saito, T., Mayadas et al., Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18). Blood 1999. 93: 4387-4394.
23. Bakema, J. E. and van Egmond, M., Immunoglobulin A: A next generation of therapeutic antibodies? MAbs 2011. 3: 352-361.
24. Morton, H. C., van den Herik-Oudijk, I. E., Vossebeld, P., Snijders, A., Verhoeven, A. J., Capel, P. J. and van de Winkel, J. G., Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J. Biol. Chem. 1995. 270: 29781-29787.
25. Wines, B. D., Trist, H. M., Monteiro, R. C., Van Kooten, C. and Hogarth, P. M., Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function. J. Biol. Chem. 2004. 279: 26339-26345.
26. Wines, B. D., Trist, H. M., Ramsland, P. A. and Hogarth, P. M., A common site of the Fc receptor gamma subunit interacts with the unrelated immunoreceptors FcalphaRI and FcepsilonRI. J. Biol. Chem. 2006. 281: 17108-17113.
27. Bakema, J. E., de Haij, S., den Hartog-Jager, C. F., Bakker, J., Vidarsson, G., van Egmond, M., van de Winkel, J. G. et al., Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction. J. Immunol. 2006. 176: 3603-3610.
28. Otten, M. A., Leusen, J. H., Rudolph, E., van der Linden, J. A., Beelen, R. H., van de Winkel, J. G. and van Egmond, M., FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI. J. Immunol. 2007. 179: 2918-2924.
29. Van den Herik-Oudijk, I. E., Capel, P. J., van der Bruggen, T. and Van de Winkel, J. G., Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms. Blood 1995. 85: 2202-2211.
30. Nohgawa, M., Sasada, M., Maeda, A., Asagoe, K., Harakawa, N., Takano, K., Yamamoto, K. et al., Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration. J. Leukoc. Biol. 1997. 62: 203-209.
31. Di Gennaro, A., Kenne, E., Wan, M., Soehnlein, O., Lindbom, L. and Haeggstrom, J. Z., Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin). Faseb. J. 2009. 23: 1750-1757.
32. Qiu, H., Johansson, A. S., Sjostrom, M., Wan, M., Schroder, O., Palmblad, J. and Haeggstrom, J. Z., Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc. Natl. Acad. Sci. USA 2006. 103: 6913-6918.
33. Fanger, M. W., Ball, E. D. and Drakeman, D. L., Comments on the Fourth International Conference on Bispecific Antibodies and Cellular Cytotoxicity, Duck Key, Florida, March 1-5, 1995. J. Hematother. 1995. 4: 345-349.
34. Frevert, C. W., Wong, V. A., Goodman, R. B., Goodwin, R. and Martin, T. R., Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods 1998. 213: 41-52.